PART 1: OVERVIEW AND ASSESSMENT
Chapter 1: TRICHOTILLO-WHAT? Definition, epidemiology, impairment
Chapter 2: PUTTING IT TOGETHER: Biopsychosocial theory of TTM
Chapter 3: WHAT IT IS AND WHAT IT ISN'T: Diagnostics, differential diagnosis, measures
Chapter 4: DOING THE DETECTIVE WORK: Comprehensive assessment/functional analysis
Chapter 5: WHAT SHOULD BE DONE? Presentation of treatment alternatives (including CBT)
Chapter 6: WHAT DO WE NEED TO KNOW? Frequently and infrequently asked questions
PART 2: TREATMENT: CORE ELEMENTS
Chapter 7: YOU CAN'T FIGHT WHAT YOU CAN'T SEE: Awareness Training and Self-Monitoring
Chapter 8: SPEED BUMPS: Stimulus Control
Chapter 9: ACTIVE STRATEGIES FOR ACTIVE HANDS: Habit Reversal/Competing Response
Chapter 10: HOLDING THE LEAD: Maintenance
PART 3: TREATMENT: ADJUNCTIVE MODULES
Introduction to Section: What are these for? How do you know if you need them?
Chapter 11 - I'M NOT SURE IF I'M READY: Module 1: motivational enhancement
Chapter 12 - CALMING DOWN: Module 2: relaxation/deep breathing
Chapter 13 - CHANGING YOUR THINKING: Module 3: cognitive restructuring
Chapter 14 - WHEN OTHER PROBLEMS ARE ALSO PRESENT: Module 4: clinical management of comorbidity
Chapter 15 - ATTENDING TO THE CONTEXT: Module 5: family assessment and family-based interventions
Chapter 16 - GETTING SUPPORT: Module 6: group based interventions
PART 4: RESOURCES FOR CLINICIANS, PATIENTS, AND FAMILIES
- Comprehensive list of professional and informational sources for clinicians, patients and families
- Literature cited
About the Author: Martin E. Franklin, Ph.D., Associate Professor of Clinical Psychology in Psychiatry and Clinical Director of the Center for the Treatment and Study of Anxiety at the University of Pennsylvania School of Medicine, received his Ph.D. in clinical psychology from the University of Rhode Island in 1993. Dr. Franklin joined the Center's faculty in 1992 upon completion of his clinical internship at the Medical College of Pennsylvania/Eastern Pennsylvania Psychiatric Institute. His scholarly publications include scientific articles and book chapters on the treatment of adult and pediatric OCD, social phobia, trichotillomania, PTSD, and readiness for behavior change. He was a member of the Expert Consensus Panel for Obsessive Compulsive Disorder that assisted with the development of treatment guidelines for adult and pediatric OCD. Dr. Franklin is a co-investigator and clinical supervisor on the Center's ongoing NIMH-funded randomized controlled trials in pediatric OCD, adult OCD, and social phobia.
David F. Tolin, Ph.D., is the founder and Director of the Anxiety Disorders Center at The Institute of Living. He is also Assistant Professor of Psychiatry at the University of Connecticut School of Medicine. Dr. Tolin received his Ph.D. from the University of Arkansas, and completed a predoctoral internship at Tufts University School of Medicine/VA Medical Center, Boston. Dr. Tolin's research and clinical interests include cognitive-behavioral therapy for anxiety disorders in adults and children, and cognitive processes that underlie anxiety disorders, particularly obsessive-compulsive disorder, posttraumatic stress disorder, and panic disorder. He is the recipient of the award for Distinguished Contribution to the Science of Psychology from the Connecticut Psychological Association, and an Early Career Award from the Anxiety Disorders Special Interest Group of the Association for Advancement of Behavior Therapy. He is a Fellow of the Council for Scientific Medicine and Mental Health.
Dr. Tolin is the author of over 90 journal articles and book chapters, and over 140 research presentations to national and international organizations. Dr. Tolin is principal investigator on the National Institute of Mental Health (NIMH)-funded studies "Stepped Care for Obsessive-Compulsive Disorder" and "Neural Mechanisms of Compulsive Hoarding," and co-investigator on the NIMH-funded studies "Psychopathology of Compulsive Hoarding" (principal investigator: R. Frost), "Treatment of Compulsive Hoarding" (principal investigator: G. Steketee), and "Screening for GAD among Frail Elderly" (principal investigator: G. Diefenbach). He has served as principal investigator on several industry-sponsored clinical trials of experimental medications. Dr. Tolin has been interviewed for The New York Times and the Associated Press, and has been a recurrent guest on The Today Show, Good Morning America and The Oprah Winfrey Show.
